Allyl methacrylate

CAS96-05-9
EC202-473-0

List details

Basic info

Status Opinion Adopted
Submitter Austria
Regulatory programme
  • Chemical registered under REACH
CLP Annex VI Index Number
  • 607-246-00-3

Classification

Harmonised classification at the time of the proposal
  • Flam. Liq. 3, H226
  • Acute Tox. 4, H302
  • Acute Tox. 4*, H312
  • Acute Tox. 3*, H331
  • Aquatic Acute 1, H400
Proposed harmonised classification by the dossier submitter
  • Flam. Liq. 3, H226
  • Acute Tox. 4, H302
  • Acute Tox. 3, H311
  • Acute Tox. 2, H330
  • Aquatic Acute 1, H400
Hazard classes open for commenting Acute Toxicity - inhalation Acute Toxicity - dermal Acute Toxicity - oral
Proposed specific concentration limits by the dossier submitter inhalation: ATE = 1,47 mg/L (vapours) dermal: ATE = 467 mg/kg bw oral: ATE = 401 mg/kg bw

Intention timeline

Date of intention 2019-10-07
Expected date of submission 2019-12-31
Submitted for accordance check 2019-12-19
Final submission date 2020-02-03
Start of consultation 2020-02-24
Deadline for commenting 2020-04-24
Date of opinion 2021-03-18
Legal deadline for opinion adoption 2021-08-04

Documents

CLH report
Comments received
Public consultations - received attachments
RAC opinion
Background document

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

This version
June 7, 2021
  • Proposed specific concentration limits by the dossier submitter: Oral: ATE = 401 mg/kg Dermal: ATE = 467 mg/kg Inhalation: ATE = 1.47 mg/L (vapours)inhalation: ATE = 1,47 mg/L (vapours) dermal: ATE = 467 mg/kg bw oral: ATE = 401 mg/kg bw
May 17, 2021
  • Background document: https://echa.europa.eu/documents/10162/624e3677-3ca3-c288-7fd8-0d896859efa6
  • Comments received: https://echa.europa.eu/documents/10162/dc071496-25c3-434f-11fe-a2bd8fd8bf2ahttps://echa.europa.eu/documents/10162/28551b37-3a9e-c956-9323-8a7aa85390f5
  • RAC opinion: https://echa.europa.eu/documents/10162/0dd2085a-b53c-4135-1eff-7e2abe74c74a
April 9, 2021
  • Name: 2-methyl-2-propenoic acid 2-propenyl ester;allyl methacrylateAllyl methacrylate
April 6, 2021
  • Date of opinion: 2021-03-18
  • Status: Opinion DevelopmentOpinion Adopted
March 27, 2021
  • Name: Allyl methacrylate2-methyl-2-propenoic acid 2-propenyl ester;allyl methacrylate
May 7, 2020
  • Comments received: https://echa.europa.eu/documents/10162/dc071496-25c3-434f-11fe-a2bd8fd8bf2a
  • Public consultations - received attachments: https://echa.europa.eu/documents/10162/982e67e9-af2c-2ece-8654-2e62e77f4a37
Feb. 25, 2020
  • CLH report: https://echa.europa.eu/documents/10162/e39a7523-143a-fb8c-c8e7-65330f5b33b8
  • Deadline for commenting: 2020-04-24
  • Final submission date: 2020-02-03
  • Hazard classes open for commenting: Acute Toxicity - inhalation Acute Toxicity - dermal Acute Toxicity - oral
  • Legal deadline for opinion adoption: 2021-08-04
  • Status: SubmittedOpinion Development
  • Start of consultation: 2020-02-24
Jan. 14, 2020
  • Harmonised classification at the time of the proposal: Aquatic Acute 1, H400
  • Proposed harmonised classification by the dossier submitter: Aquatic Acute 1, H400
  • Proposed specific concentration limits by the dossier submitter: Oral: ATE = 401 mg/kg Dermal: ATE = 467 mg/kg Inhalation: ATE = 1.47 mg/L (vapours)
  • Status: IntentionSubmitted
  • Submitted for accordance check: 2019-12-19
Nov. 26, 2019
  • Regulatory programme: Chemical registered under REACH
Add the related substance to your watchlist to monitor this regulatory record.